Biometrijske karakteristike očiju prevremeno rođenih beba
Sažetak
Uvod/Cilj. Prevremeno rođenje i prematurna retinopatija (ROP) mogu dovesti do nastanka refraktivnih mana, uticajem na optičke i biometrijske karakteristike oka. Cilj ovog rada bio je da se uporede promene u aksijalnoj dužini oka, dubini prednje očne komore i debljini sočiva prematurusa sa i bez ROP tokom prve godine života. Metode. Ispitivanje je sprovedeno kao prospektivna longitudinalna studija, koja je obuhvatila 87 prevremeno rođenih beba. U uzrastu od 3 i 12 meseci urađen je pregled očnog dna i merenje aksijalne dužine oka, dubine prednje očne komore i debljine očnog sočiva. Prema nalazu na očnom dnu 3 meseca posle rođenja bebe su podeljene u dve grupe, sa i bez ROP i i izmerene vrednosti praćenih parametara su upoređene. Rezultati. Prilikom pregleda beba sa 3 meseca kod 60,92% njih je ustanovljen ROP. Prosečne vrednosti merenih parametara na desnom i levom oku u grupi sa ROP bile su: aksijalna dužina 16,56 mm i 16,53 mm, dubina prednje očne komore 2,34 mm i 2,38 mm i debljina sočiva 4,04 mm i 3,96 mm na desnom, odnosno levom oku. U grupi bez ROP ove vrednosti na desnom i levom oku bile su: aksijalna dužina 17,06 mm i 17,08 mm, dubina prednje komore 2,31 mm i 2,39 mm i debljina sočiva 4,16 mm i 4,14 mm. Sa 12 meseci 28,74% dece je imalo promene na retini kao posledice tretmana ROP. U grupi sa ROP pri prvom pregledu, aksijalne dužine bile su 19,94 mm na oba oka, dubine prednje komore 3,01 mm i 2,99 mm, a debljine sočiva 4,28 mm i 4,29 mm na desnom, odnosno levom oku. U grupi bez ROP aksijalne dužine desnog, odnosno levog oka bile su 20,64 mm i 20,29 mm, dubine komore 3,10 mm na oba oka, a debljine sočiva 4,37 mm i 4,36 mm, desno i levo. Zaključak. U grupi dece sa ROP aksijalna dužina oka sa 3 i 12 meseci bila je statistički značajno manja u odnosu na grupu bez promena na retini. Statistički značajna razlika nije nađena između grupe sa i bez ROP poređenjem parametara očne komore i sočiva
Reference
Birch EE, O'Connor AR. Preterm birth and visual development. Semin Neonatol 2001; 6(6): 487−97.
Oros A. Modern approach to the development of the retina in premature infants. In: Dedović Bjelajac B, Kostić Todorović M, Marković M, Mileusnić Milenović R, Mušić Trninić N, Oros A, et al, editors. Clinical seminars. Belgrade: Institute for neonatology; 2013. p. 119−27. (Serbian)
Madan A, Jan JE, Good WV. Visual development in preterm infants. Dev Med Child Neurol 2005; 47(4): 276−80.
van Sorge AJ, Schalij-Delfos NE, Kerkhoff FT, van Rijn LJ, van Hillegersberg JL, van Liempt IL, et al. Reduction in screening for retinopathy of prematurity through risk factor adjusted inclusion criteria. Br J Ophthalmol 2013; 97(9): 1143−7.
Oros A. Detection, treatment and prevention of the development of retinopathy of prematurity [thesis]. Novi Sad: Faculty of Medicine University of Novi Sad; 2002. (Serbian)
Budd SJ, Hartnet ME. Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. Arch Ophthalmol 2010; 128(5): 589−95.
Oros A. Etiology and pathogenesis of retinopathy of prematurity. In: Oros A, editor. Retinopathy of prematurity. Belgrade: Zadužbina Andrejević; 2003. p. 22−54. (Serbian)
Fielder AR, Reynolds JD. Retinopathy of prematurity: clinical aspects. Semin Neonatol 2001; 6(6): 461−75.
Pierce LM, Raab EL, Holzman IR, Ginsburg RN, Brodie SE, Stroustrup A. Importance of birth weight as a risk factor for severe retinopathy of prematurity when gestational age is 30 or more weeks. Am J Ophthalmol 2014; 157(6): 1227−30.e2.
Fierson WM. American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131(1): 189−95.
Fielder AR, Levene MI. Screening for retinopathy of prematurity. Arch Dis Child 1992; 67 (7 Spec No): 860−7.
Kennedy KA, Wrage LA, Higgins RD, Finer NN, Carlo WA, Walsh MC, et al. Evaluating etinopathy of prematurity screening guidelines for 24-27 week gestational age infants. J Perinatol 2014; 34(4): 311−8.
Demorest BH. Retinopathy of prematurity requires diligent follow-p care. Surv Ophthalmol 1996; 41(2): 175−8.
Saunders KJ, McCulloch DL, Shepherd AJ, Wilkinson AG. Emmetropisation following preterm birth. Br J Ophthalmol 2002; 86(9): 1035−40.
Hsieh CJ, Liu JW, Huang JS, Lin KC. Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age: A prospective controlled cohort study. Koahsinug J Med Sci 2012; 28(4): 204−11.
Siegwart JT Jr, Norton TT. Perspective: how might emmetropization and genetic factors produce myopia in normal eyes? Optom Vis Sci 2011; 88(3): E365−72.
Troilo D, Wallman J. The regulation of eye gowth and refractive state: an experimental study of emmetropization. Vision Res 1991; 31(7−8): 1237−50.
Mutti DO, Mitchell GL, Jones LA, Friedman NE, Frane SL, Lin WK, et al. Axial growth and changes in lenticular and corneal power during emmetropization in infants. Invest Ophthalmol Vis Sci 2005; 46(9): 3074−80.
Cosgrave E, Scott C, Goble R. Ocular findings in low birthweight and premature babies in the first year: Do we need to screen? Eur J Ophthalmol 2008; 18(1): 104−11.
Mutti DO, Hayes JR, Mitchell GL, Jones LA, Moeschberger ML, Cotter SA, et al. Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci 2007; 48: 2510−9.
Choi MY, Park IK, Yu YS. Long term refractive outcome in eyes of preterm infants with and without retinopathy of prematurity: comparison of keratometric value, axial length, anterior chamber depth, and lens thicknes. Br J Ophthalmol 2000; 84(2): 138−43.
Chen TC, Tsai TH, Shih YF, Yeh PT, Yang CH, Hu FC, et al. Long–term Evaluation of Refractive Status and Optical Components in Eyes of Children Born Prematurely. Invest Ophthalmol Vis Sci 2010; 51(12): 6140−8.
Cook A, White S, Batterbury M, Clark D. Ocular growth and refractive error development in premature infants with or without retinopathy of prematurity. Invest Ophthalmol Vis Sci 2008; 49(12): 5199−207.
O'Brien C, Clark D. Ocular biometry in pre-term infants without retinopathy of prematurity. Eye (Lond) 1994; 8( Pt 6): 662−5.
Laws DE, Haslett R, Ashby D, O'Brien C, Clark D. Axial length biometry in infants with retinopathy of prematurity. Eye (Lond) 1994; 8( Pt 4): 427−30.
McColm JR, Fleck BW. Retinopathy of prematurity: causation. Semin Neonatol 2001; 6(6): 453−60.
Ho SF, Mathew MR, Wykes W, Lavy T, Marshall T. Retinopathy of prematurity: an optimum screening strategy. J AAPOS 2005; 9(6): 584−8.
Mathew MR, Fern AI, Hill R. Retinopathy of prematurity: are we screening too many babies? Eye (Lond) 2002;16(5): 538−42.
Shah PK, Ramakrishnan M, Sadat B, Bachu S, Narendran V, Kalpana N. Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity. Oman J Ophthalmol 2014; 7(3): 116−9
Fledelius HC, Fledelius C. Eye Size in Treshold Retinopathy of Prematurity, Based on a Danish Preterm Infant Series: Early Axial Eye Growth, Pre- and Postnatal Aspects. Invest Ophthalmol Vis Sci 2012; 53(7): 4177−84.
Pennie FC, Wood IC, Olsen C, White S, Charman WN. A longitudinal study of the biometric and refractive changes in full-term infants during the first year of life. Vision Res 2001; 41(21): 2799−810.
Wang J, Ren X, Shen L, Yanni SE, Leffler JN, Birch EE. Development of Refractive Error in Individual Children With Regressed Retinopathy of Prematurity. Invest Ophthalmol Vis Sci 2013; 54(9): 6018−24.